Prognostic implications of surrogate markers of atherosclerosis in low to intermediate risk patients with Type 2 Diabetes

Cardiovascular Diabetology

Volumn 11, Issue , 2012, Pages

  Lau, Kui Kai ^a,b   Wong, Yuen Kwun ^a   Chan, Yap Hang ^a   Yiu, Kai Hang ^a,b   Teo, Kay Cheong ^a   Li, Leonard S ^a   Ho, Shu Leong ^a,b   Chan, Koon Ho ^a,b   Siu, Chung Wah ^a,b   Tse, Hung Fat ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Type 2 diabetes mellitus; Vascular markers of atherosclerosis

Indexed keywords

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERIAL STIFFNESS; ARTERY ENDOTHELIUM; ARTICLE; ATHEROMA; ATHEROSCLEROSIS; BRACHIAL ARTERY; BRACHIAL ARTERY ENDOTHELIAL FUNCTION; CAROTID ATHEROSCLEROSIS; CHINESE; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY CALCIFICATION; DISEASE DURATION; DISEASE MARKER; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM;

EID: 84865060103     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-11-101     Document Type: Article

References (38)

1. Rytter L, Troelsen S, Beck-Nielsen H. Prevalence and mortality of acute myocardial infarction in patients with diabetes. Diabetes Care 1985, 8(3):230-234. 10.2337/diacare.8.3.230, 4006657.
2. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979, 241(19):2035-2038. 10.1001/jama.1979.03290450033020, 430798.
3. Lavy S, Melamed E, Cahane E, Carmon A. Hypertension and diabetes as risk factors in stroke patients. Stroke 1973, 4(5):751-759. 10.1161/01.STR.4.5.751, 4751086.
4. D'Agostino RB, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001, 286(2):180-187. 10.1001/jama.286.2.180, 11448281.
5. Ramachandran S, French JM, Vanderpump MP, Croft P, Neary RH. Using the Framingham model to predict heart disease in the United Kingdom: retrospective study. BMJ 2000, 320(7236):676-677. 10.1136/bmj.320.7236.676, 27308, 10710574.
6. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetiere P, Jousilahti P, Keil U, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003, 24(11):987-1003. 10.1016/S0195-668X(03)00114-3, 12788299.
7. Liu J, Hong Y, D'Agostino RB, Wu Z, Wang W, Sun J, Wilson PW, Kannel WB, Zhao D. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese multi-provincial cohort study. JAMA 2004, 291(21):2591-2599. 10.1001/jama.291.21.2591, 15173150.
8. Coleman RL, Stevens RJ, Retnakaran R, Holman RR. Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes. Diabetes Care 2007, 30(5):1292-1293. 10.2337/dc06-1358, 17290036.
9. McEwan P, Williams JE, Griffiths JD, Bagust A, Peters JR, Hopkinson P, Currie CJ. Evaluating the performance of the Framingham risk equations in a population with diabetes. Diabet Med 2004, 21(4):318-323. 10.1111/j.1464-5491.2004.01139.x, 15049932.
10. van der Heijden AA, Ortegon MM, Niessen LW, Nijpels G, Dekker JM. Prediction of coronary heart disease risk in a general, pre-diabetic, and diabetic population during 10 years of follow-up: accuracy of the Framingham, SCORE, and UKPDS risk functions: The Hoorn Study. Diabetes Care 2009, 32(11):2094-2098. 10.2337/dc09-0745, 2768197, 19875606.
11. Standards of medical care in diabetes--2012. Diabetes Care 2012, 35(Suppl 1):S11-S63.
12. Yeboah J, Folsom AR, Burke GL, Johnson C, Polak JF, Post W, Lima JA, Crouse JR, Herrington DM. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation 2009, 120(6):502-509. 10.1161/CIRCULATIONAHA.109.864801, 2740975, 19635967.
13. Ali YS, Rembold KE, Weaver B, Wills MB, Tatar S, Ayers CR, Rembold CM. Prediction of major adverse cardiovascular events by age-normalized carotid intimal medial thickness. Atherosclerosis 2006, 187(1):186-190. 10.1016/j.atherosclerosis.2005.09.003, 16233899.
14. Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, Vita JA, Levy D, Benjamin EJ. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation 2010, 121(4):505-511. 10.1161/CIRCULATIONAHA.109.886655, 2836717, 20083680.
15. Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, Folsom AR, Hirsch AT, Dramaix M, deBacker G, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008, 300(2):197-208. 2932628, 18612117.
16. Elkeles RS, Godsland IF, Feher MD, Rubens MB, Roughton M, Nugara F, Humphries SE, Richmond W, Flather MD. Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: the PREDICT study. Eur Heart J 2008, 29(18):2244-2251. 10.1093/eurheartj/ehn279, 18573867.
17. Lakoski SG, Greenland P, Wong ND, Schreiner PJ, Herrington DM, Kronmal RA, Liu K, Blumenthal RS. Coronary artery calcium scores and risk for cardiovascular events in women classified as "low risk" based on Framingham risk score: the multi-ethnic study of atherosclerosis (MESA). Arch Intern Med 2007, 167(22):2437-2442. 10.1001/archinte.167.22.2437, 18071165.
18. Lau KK, Chan YH, Yiu KH, Tam S, Li SW, Lau CP, Tse HF. Incremental predictive value of vascular assessments combined with the Framingham Risk Score for prediction of coronary events in subjects of low-intermediate risk. Postgrad Med J 2008, 84(989):153-157. 10.1136/pgmj.2007.064089, 18372487.
19. Murphy TP, Dhangana R, Pencina MJ, D'Agostino RB. Ankle-brachial index and cardiovascular risk prediction: an analysis of 11,594 individuals with 10-year follow-up. Atherosclerosis 2012, 220(1):160-167. 10.1016/j.atherosclerosis.2011.10.037, 22099055.
20. Polak JF, Pencina MJ, Pencina KM, O'Donnell CJ, Wolf PA, D'Agostino RB. Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med 2011, 365(3):213-221. 10.1056/NEJMoa1012592, 3153949, 21774709.
21. Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 2004, 291(2):210-215. 10.1001/jama.291.2.210, 14722147.
22. Kavousi M, Elias-Smale S, Rutten JH, Leening MJ, Vliegenthart R, Verwoert GC, Krestin GP, Oudkerk M, de Maat MP, Leebeek FW, et al. Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study. Ann Intern Med 2012, 156(6):438-444.
23. Yoshida M, Mita T, Yamamoto R, Shimizu T, Ikeda F, Ohmura C, Kanazawa A, Hirose T, Kawamori R, Watada H. Combination of the framingham risk score and carotid intima-media thickness improves the prediction of cardiovascular events in patients with type 2 diabetes. Diabetes Care 2012, 35(1):178-180. 10.2337/dc11-1333, 22028278.
24. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998, 15(7):539-553. 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S, 9686693.
25. Yue WS, Lau KK, Siu CW, Wang M, Yan GH, Yiu KH, Tse HF. Impact of glycemic control on circulating endothelial progenitor cells and arterial stiffness in patients with type 2 diabetes mellitus. Cardiovasc Diabetol 2011, 10:113. 10.1186/1475-2840-10-113, 3258289, 22185563.
26. Whitworth JA. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003, 21(11):1983-1992.
27. Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001, 285(19):2486-2497. 10.1001/jama.285.19.2486, 11368702.
28. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 1999, 130(6):461-470.
29. Tsuchikura S, Shoji T, Kimoto E, Shinohara K, Hatsuda S, Koyama H, Emoto M, Nishizawa Y. Brachial-ankle pulse wave velocity as an index of central arterial stiffness. J Atheroscler Thromb 2010, 17(6):658-665. 10.5551/jat.3616, 20467192.
30. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, Csiba L, Desvarieux M, Ebrahim S, Fatar M, et al. Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 2007, 23(1):75-80. 10.1159/000097034, 17108679.
31. Yiu KH, Mok MY, Wang S, Ooi GC, Khong PL, Lau CS, Tse HF. Prognostic role of coronary calcification in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Rheumatol 2012, 30(3):345-350.
32. Wu Y, Liu X, Li X, Li Y, Zhao L, Chen Z, Rao X, Zhou B, Detrano R, Liu K. Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults. Circulation 2006, 114(21):2217-2225. 10.1161/CIRCULATIONAHA.105.607499, 17088464.
33. Bernard S, Serusclat A, Targe F, Charriere S, Roth O, Beaune J, Berthezene F, Moulin P. Incremental predictive value of carotid ultrasonography in the assessment of coronary risk in a cohort of asymptomatic type 2 diabetic subjects. Diabetes Care 2005, 28(5):1158-1162. 10.2337/diacare.28.5.1158, 15855582.
34. Rana JS, Gransar H, Wong ND, Shaw L, Pencina M, Nasir K, Rozanski A, Hayes SW, Thomson LE, Friedman JD, et al. Comparative value of coronary artery calcium and multiple blood biomarkers for prognostication of cardiovascular events. Am J Cardiol 2012, 109(10):1449-1453. 10.1016/j.amjcard.2012.01.358, 22425333.
35. Raggi P, Shaw LJ, Berman DS, Callister TQ. Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol 2004, 43(9):1663-1669. 10.1016/j.jacc.2003.09.068, 15120828.
36. Wong ND, Nelson JC, Granston T, Bertoni AG, Blumenthal RS, Carr JJ, Guerci A, Jacobs DR, Kronmal R, Liu K, et al. Metabolic syndrome, diabetes, and incidence and progression of coronary calcium: the Multiethnic Study of Atherosclerosis study. JACC Cardiovasc Imaging 2012, 5(4):358-366. 10.1016/j.jcmg.2011.12.015, 22498324.
37. Chu ZG, Yang ZG, Dong ZH, Zhu ZY, Peng LQ, Shao H, He C, Deng W, Tang SS, Chen J. Characteristics of coronary artery disease in symptomatic type 2 diabetic patients: evaluation with CT angiography. Cardiovasc Diabetol 2010, 9:74. 10.1186/1475-2840-9-74, 2992482, 21067585.
38. Gomez-Marcos MA, Recio-Rodriguez JI, Patino-Alonso MC, Agudo-Conde C, Gomez-Sanchez L, Rodriguez-Sanchez E, Gomez-Sanchez M, Garcia-Ortiz L. Yearly evolution of organ damage markers in diabetes or metabolic syndrome: data from the LOD-DIABETES study. Cardiovasc Diabetol 2011, 10:90. 10.1186/1475-2840-10-90, 3214163, 21999369.